2004, Number 4
<< Back Next >>
Med Cutan Iber Lat Am 2004; 32 (4)
Recurrent Aphthous Stomatitis and Cytokines Presentation
Miret MA, Mérida MT, Corado J, Vivas S, Toro R, D'Alessandro C, Escalona C
Language: Spanish
References: 15
Page: 151-156+
PDF size: 575.07 Kb.
ABSTRACT
Recurrent Aphthous Stomatitis (SRA) is an inflammatory chronic disesase, characterized by the presence of recurrent and painful ulcerations in the oral mucous.
Objective: To determine the possible role of the TGF-Β, IL-1, ICAM-1 and T cells population (CD4, CD8, CD45RO) and histiocitic CD68 in the immunopathogenesis of the SRA.
Material and Methods: Twelve patients with the SRA diagnosis and 15 patients without SRA as controls material, were enrolled into the study, all patients were from the Dermatological out patients service at the Hospital Central de Valencia and Facultad de Odontologia from Universidad de Carabobo, Valencia-Venezuela. Age rate was 52.5 years, and the relation gender was 1:1. It was excluded all patients with the diagnosis as Herpes type1 or 2, migratory glossitis, lichen rubber planus and any type of collagen disease. Cytological study from salivary smears, ICAM-1 in saliva (ELISA) and IL-1 by seric levels was showed. Immunohistochemical study was made for TGF-Β, CD4, CD3, CD45RO, CD68 expression.
Results: ICAM-1 levels were high in SRA patient, TGF-Β was more in SRA (++/ +++) patients than no SRA patients (+). T cells CD8 population were more common than T cells CD4 (1568/-190) in SRA patients, histiocitic poblation CD68 was high (++/+++) and IL-1α medium was 149.63 pg/ml.
Conclusion: The immunological amplication in the SRA showed as ICAM-1,IL-1, TGF-Β and T cells population is the way to get more information about the pathogenesis and systemic implications of SRA, we suggest to all investigators this way in order to understand the pathogenesis of this disease.
REFERENCES
Yamamoto M, Maehara Y, Sakaguchi Y, Kusumoto T, et al. Serum citokines, receptor interleukin-2 and soluble intercellular adhesion molecular-1 in oral disorders. Oral Surg Oral Med Oral Pathol 1995; 78: 727-35.
Dinarello C. Anti-cytokines strategies. Eur Cytokine Netw 1992; 3: 7-17.
Olaso R, Pairault C, Saez JM, Habert R. Transforming growth factor b 3 in the fetal and neonatal rat testis: immunolocalization and effect on fetal Leydig cell function. Histochem Cell Biol 1999; 112: 247-54.
Schuster and Krieglstein K. Mechanisms of TGF b mediated apoptosis. Cell Tissue Res 2001; 307: 1-14.
Tamariz DE, Castro MF, Kuri HW. Growth factors and extra cellular matrix proteins during wound healing promoted with frozen cultured sheets of human epidermal kratinocytes. Cell Tissue Res 2002; 307:79-89.
Miret A, Chacon de Petrola P, Flores ME, Mérida MT, et al. Determinación de los niveles de ICAM-1 e IgE secretora en saliva de pacientes con diagnóstico de estomatitis aftosa recurrente. Salus 1998; 2: 10-8.
Jiménez SY, Bagán SJ, Milián M. Minor recurrent aphthous stomatitis. Clinic characteristics hematologic deficiencies in 60 pacients. J Oral Med 1996; 1: 11-4.
Buno IJ. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4 and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Dermatol 1998; 134: 827-31.
Gold I. The role for transforming growth factor beta (TGF b) in human cancer. Crit Rev Oncog 1999; 10: 303-60.
Roberts AB, Sporn MB. The transforming growth factor β. Handbk Exp Pharm 1990; 95: 419-58.
Roberts AB, Sporn MB, Assoian RK. Transforming growth factor type β rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 1986; 83: 4167-71.
Ijnotz RA, Endo T, Massagué L. Regulation of fibronectin and type 1 collagen mRNA levels by transforming growth factor β. J Biol Chem 1987; 262: 6443-6.
Hogg N, et al. Structure and function of adhesion receptors in leukocites trassicking. Inmunology Today 1995: 327-9.
Roitt. Inmunología fundamentos. 10ª edición. Madrid-España. Editorial Médica Panamericana S.A. 2003.
Eversole L. Inmunopatology of oral mucosal ulcerative, desquamative and bullous disease. Oral Surgery . Oral Medicine and Oral Patology 1994; 77: 565-71.